Presentation on Diagnostics Reimbursement
Related Content
- New Report Analyzes Impact of Limitations of Current Reimbursement System on Development of Novel Diagnostics
- Challenges in Reimbursement Hamper Development of Novel Diagnostics
- New Report Analyzes Impact of Limitations of Current Reimbursement System on Development of Novel Diagnostics
- Recommendations for Novel Diagnostics Coverage and Reimbursement
Sara Radcliffe, BIO Executive Vice President Health, presents an overview of BIO's commissioned study on Diagnostics Reimbursement at the Harvard Medical Center Partners Healthcare Personalized Medicine Conference: Impacting Healthcar.
Receive our newsletter from BIOtechNOW
